|
|
|
|
|
Industry News |
 |
|
Advertisement |
Three Key Critical Considerations Before Embarking on Decentralized Trials Tuesday, January 28, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now
|
Q&A |
 |
RNA Therapies Emerge for Genetic Diseases |
Therapies aimed at correcting genes that cause diseases are gaining ground in biopharma, some are even specializing in specific mechanisms of action by targeting and modifying RNA through temporary and ongoing treatment. CEO at ProQR Therapeutics, Daniel de Boer, discusses how they are advancing RNA therapies in retinal disorders.
... /Read more/ |
|
|
|
|
|